A ransomware attack on Synnovis, a key service partner for several London hospitals, has significantly disrupted pathology services, impacting patient care. While emergency care continues, there are reports of services, particularly blood transfusions, and certain procedures being cancelled or redirected. Cybersecurity experts are urgently working to assess and mitigate the incident’s impact, with updates to be provided to keep the public informed.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
